Unique ID issued by UMIN | UMIN000035447 |
---|---|
Receipt number | R000040386 |
Scientific Title | Construction of compound detection system by mass spectrometry for biological samples obtained at Critical Care Center and examination of its operability |
Date of disclosure of the study information | 2019/01/05 |
Last modified on | 2024/03/04 13:43:26 |
Construction of compound detection system by mass spectrometry for biological samples obtained at Critical Care Center and examination of its operability
Construction of compound detection system by mass spectrometry for biological samples obtained at Critical Care Center and examination of its operability
Construction of compound detection system by mass spectrometry for biological samples obtained at Critical Care Center and examination of its operability
Construction of compound detection system by mass spectrometry for biological samples obtained at Critical Care Center and examination of its operability
Japan |
Drug intoxication
Emergency medicine |
Others
NO
To construct an identification and concentration measurement system with high performance liquid chromatography - Hybrid Quadrupole-Orbitrap Mass Spectrometer, gas chromatograph mass spectrometer and high performance liquid chromatography for toxic substances in biological substances from patients in Critical Care Center and to investigate its clinical operability
Others
To add new compounds as substances to be detected, and investigate the extensibility of this system
Exploratory
Pragmatic
Not applicable
The type and the frequency of detection of candidate compounds such as toxic substances detected by this system from real clinical biological sample
Difference between toxic substances identified in existing tests and compounds such as toxic substances identified in this system
Observational
Not applicable |
Not applicable |
Male and Female
1.Patients who visited the Advanced Critical Care and Emergency Center in Teikyo University Hospital (including emergency patients)
2.Patients suspected of poisoning, which is written in the medical record.
3.Patient who collected blood or urine for treatment.
1.Patients or family of whom expressed an intention to refuse to participate in this study.
2.Patients whose residual specimens are inadequate for this study.
3.Those who are judged inappropriate by the investigators.
500
1st name | Kiyoko |
Middle name | |
Last name | Kaneko |
Faculty of Pharma-Science, Teikyo University
Laboratory of Biomedical and Analytical Sciences
1738605
2-11-1 Kaga Itabashi-ku, Tokyo
03-3964-1211
kikaneko@pharm.teikyo-u.ac.jp
1st name | Hiroyuki |
Middle name | |
Last name | Hosono |
Teikyo University Hospital
Center for Clinical Research & Trial
1738606
2-11-1 Kaga Itabashi-ku, Tokyo
03-3964-1211
https://www.teikyo-u.ac.jp/affiliate/public_projects_201905_04.pdf
hhosono@med.teikyo-u.ac.jp
Teikyo University
Ministry of Education, Culture, Sports, Science and Technology
Japanese Governmental office
Japan
Teikyo University Review Board
2-11-1 Kaga Itabashi-ku, Tokyo,173-8605
03-3964-7256
turb-office@teikyo-u.ac.jp
NO
帝京大学医学部附属病院(東京都)
2019 | Year | 01 | Month | 05 | Day |
Published
https://link.springer.com/article/10.2116/analsci.20P252
142
Completed
2018 | Year | 10 | Month | 16 | Day |
2018 | Year | 10 | Month | 16 | Day |
2018 | Year | 10 | Month | 16 | Day |
2023 | Year | 03 | Month | 31 | Day |
2023 | Year | 03 | Month | 31 | Day |
2023 | Year | 03 | Month | 31 | Day |
2023 | Year | 03 | Month | 31 | Day |
Observational research using residual specimens
2019 | Year | 01 | Month | 05 | Day |
2024 | Year | 03 | Month | 04 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040386